Pre-eclampsia secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Ochuko Ajari (talk | contribs) Created page with "__NOTOC__ {{Pre-eclampsia}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==References== {{Reflist..." |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Pre-eclampsia}} | {{Pre-eclampsia}} | ||
{{CMG}} {{AE}} {{Sara.Zand}} | |||
== Overview == | |||
Maternal monitoring in preeclampsia should include BP monitoring, repeated assessments for proteinuria if it is not already present, clinical assessment including clonus, and a minimum of twice weekly blood tests for hemoglobin, platelet count, and tests of liver and renal function, including uric acid, the latter being associated with worse maternal and fetal outcomes. | |||
==References== | ==References== | ||
Revision as of 17:06, 10 October 2020
|
Pre-eclampsia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pre-eclampsia secondary prevention On the Web |
|
American Roentgen Ray Society Images of Pre-eclampsia secondary prevention |
|
Risk calculators and risk factors for Pre-eclampsia secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Zand, M.D.[2]
Overview
Maternal monitoring in preeclampsia should include BP monitoring, repeated assessments for proteinuria if it is not already present, clinical assessment including clonus, and a minimum of twice weekly blood tests for hemoglobin, platelet count, and tests of liver and renal function, including uric acid, the latter being associated with worse maternal and fetal outcomes.